Document is current
Any future updates will be listed below
-
Authors
Saha, Prasenjit Prasad
Gogonea, Valentin
Sweet, Wendy
Mohan, Maradumane L. http://orcid.org/0000-0003-4224-150X
Singh, Khuraijam Dhanachandra
Anderson, James T. http://orcid.org/0000-0003-2380-2527
Mallela, Deepthi http://orcid.org/0000-0002-2703-4353
Witherow, Conner
Kar, Niladri http://orcid.org/0000-0002-3825-2217
Stenson, Kate
Harford, Terri http://orcid.org/0000-0001-6590-0673
Fischbach, Michael A. http://orcid.org/0000-0003-3079-8247
Brown, J. Mark http://orcid.org/0000-0003-2708-7487
Karnik, Sadashiva S. http://orcid.org/0000-0003-0746-2753
Moravec, Christine S.
DiDonato, Joseph A. http://orcid.org/0000-0002-1641-1758
Naga Prasad, Sathyamangla Venkata
Hazen, Stanley L. http://orcid.org/0000-0001-7124-6639
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (P01HL147823, R01HL103866, R01HL167831)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
American Heart Association (20POST35210937)
- License Information
-
More Information
Article History
Received: 19 June 2023
Accepted: 16 July 2024
First Online: 6 August 2024
Competing interests
: Dr. Hazen reports being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, being a paid consultant for Procter & Gamble and Zehna Therapeutics, having received research funds from Procter & Gamble, Zehna Therapeutics, and Roche Diagnostics, and being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab and P&G. The remaining authors declare no competing interests.
